These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


103 related items for PubMed ID: 11459808

  • 1. Targeted overexpression of IGF-I in smooth muscle cells of transgenic mice enhances neointimal formation through increased proliferation and cell migration after intraarterial injury.
    Zhu B, Zhao G, Witte DP, Hui DY, Fagin JA.
    Endocrinology; 2001 Aug; 142(8):3598-606. PubMed ID: 11459808
    [Abstract] [Full Text] [Related]

  • 2. Targeted disruption of the pregnancy-associated plasma protein-A gene is associated with diminished smooth muscle cell response to insulin-like growth factor-I and resistance to neointimal hyperplasia after vascular injury.
    Resch ZT, Simari RD, Conover CA.
    Endocrinology; 2006 Dec; 147(12):5634-40. PubMed ID: 16959843
    [Abstract] [Full Text] [Related]

  • 3. Constitutive expression of pregnancy-associated plasma protein-A in arterial smooth muscle reduces the vascular response to injury in vivo.
    Bale LK, Resch ZT, Harstad SL, Overgaard MT, Conover CA.
    Am J Physiol Endocrinol Metab; 2013 Jan 15; 304(2):E139-44. PubMed ID: 23169786
    [Abstract] [Full Text] [Related]

  • 4. Overexpression of insulin-like growth factor-binding protein-4 (IGFBP-4) in smooth muscle cells of transgenic mice through a smooth muscle alpha-actin-IGFBP-4 fusion gene induces smooth muscle hypoplasia.
    Wang J, Niu W, Witte DP, Chernausek SD, Nikiforov YE, Clemens TL, Sharifi B, Strauch AR, Fagin JA.
    Endocrinology; 1998 May 15; 139(5):2605-14. PubMed ID: 9564877
    [Abstract] [Full Text] [Related]

  • 5. Smooth muscle-targeted overexpression of insulin-like growth factor I results in enhanced vascular contractility.
    Zhao G, Sutliff RL, Weber CS, Wang J, Lorenz J, Paul RJ, Fagin JA.
    Endocrinology; 2001 Feb 15; 142(2):623-32. PubMed ID: 11159833
    [Abstract] [Full Text] [Related]

  • 6. Neutralization of interleukin-18 inhibits neointimal formation in a rat model of vascular injury.
    Maffia P, Grassia G, Di Meglio P, Carnuccio R, Berrino L, Garside P, Ianaro A, Ialenti A.
    Circulation; 2006 Aug 01; 114(5):430-7. PubMed ID: 16864728
    [Abstract] [Full Text] [Related]

  • 7. Dominant negative insulin-like growth factor-1 receptor inhibits neointimal formation through suppression of vascular smooth muscle cell migration and proliferation, and induction of apoptosis.
    Lim HJ, Park HY, Ko YG, Lee SH, Cho SY, Lee EJ, Jameson JL, Jang Y.
    Biochem Biophys Res Commun; 2004 Dec 17; 325(3):1106-14. PubMed ID: 15541402
    [Abstract] [Full Text] [Related]

  • 8. Cortistatin inhibits migration and proliferation of human vascular smooth muscle cells and decreases neointimal formation on carotid artery ligation.
    Duran-Prado M, Morell M, Delgado-Maroto V, Castaño JP, Aneiros-Fernandez J, de Lecea L, Culler MD, Hernandez-Cortes P, O'Valle F, Delgado M.
    Circ Res; 2013 May 24; 112(11):1444-55. PubMed ID: 23595952
    [Abstract] [Full Text] [Related]

  • 9. PPARγ attenuates intimal hyperplasia by inhibiting TLR4-mediated inflammation in vascular smooth muscle cells.
    Zhang LL, Gao CY, Fang CQ, Wang YJ, Gao D, Yao GE, Xiang J, Wang JZ, Li JC.
    Cardiovasc Res; 2011 Dec 01; 92(3):484-93. PubMed ID: 21880694
    [Abstract] [Full Text] [Related]

  • 10. Expression of insulin-like growth factor I by activated hepatic stellate cells reduces fibrogenesis and enhances regeneration after liver injury.
    Sanz S, Pucilowska JB, Liu S, Rodríguez-Ortigosa CM, Lund PK, Brenner DA, Fuller CR, Simmons JG, Pardo A, Martínez-Chantar ML, Fagin JA, Prieto J.
    Gut; 2005 Jan 01; 54(1):134-41. PubMed ID: 15591519
    [Abstract] [Full Text] [Related]

  • 11. The cyclolignan picropodophyllin attenuates intimal hyperplasia after rat carotid balloon injury by blocking insulin-like growth factor-1 receptor signaling.
    Razuvaev A, Henderson B, Girnita L, Larsson O, Axelson M, Hedin U, Roy J.
    J Vasc Surg; 2007 Jul 01; 46(1):108-15. PubMed ID: 17606126
    [Abstract] [Full Text] [Related]

  • 12. Beta3-integrin mediates smooth muscle cell accumulation in neointima after carotid ligation in mice.
    Choi ET, Khan MF, Leidenfrost JE, Collins ET, Boc KP, Villa BR, Novack DV, Parks WC, Abendschein DR.
    Circulation; 2004 Mar 30; 109(12):1564-9. PubMed ID: 15007005
    [Abstract] [Full Text] [Related]

  • 13. Perivascular release of insulin-like growth factor-1 limits neointima formation in the balloon-injured artery by redirecting smooth muscle cell migration.
    Wong AH, Amabile PG, Yuksel E, Waugh JM, Dake MD.
    J Vasc Interv Radiol; 2001 Mar 30; 12(3):347-50. PubMed ID: 11287513
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Thrombospondin-1 activates medial smooth muscle cells and triggers neointima formation upon mouse carotid artery ligation.
    Moura R, Tjwa M, Vandervoort P, Cludts K, Hoylaerts MF.
    Arterioscler Thromb Vasc Biol; 2007 Oct 30; 27(10):2163-9. PubMed ID: 17761938
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Inhibition of intimal thickening in the rat carotid artery injury model by a nontoxic Ras inhibitor.
    George J, Sack J, Barshack I, Keren P, Goldberg I, Haklai R, Elad-Sfadia G, Kloog Y, Keren G.
    Arterioscler Thromb Vasc Biol; 2004 Feb 30; 24(2):363-8. PubMed ID: 14670932
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.